Observational analysis shows 2.6-fold higher risk for hypertensive pregnancy complications with slow β-hCG elevation, suggesting earlier monitoring might help.
Patients with slow β-hCG elevation in the fifth gestational week were approximately at a 2.6-fold higher risk for pregnancy induced hypertension complications when compared to patients with a normal β-hCG elevation. The early detection of this previously unrecognized risk group could allow tighter follow-up during pregnancy, which could potentially reduce these complications.
No takes yet. Share an insight, caveat, or question.
Wertheimer et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: